Savara (SVRA) Other Non-Current Assets (2010 - 2026)

Savara's (SVRA) quarterly Other Non-Current Assets came in at $11.4 million in Q1 2026, up 5.88% year-on-year from $10.7 million in Q1 2025, and down 2.34% on a QoQ basis from $11.6 million in Q4 2025.

Savara (SVRA) Other Non-Current Assets (2010 - 2026) Analysis & Trends

Savara (SVRA) has 17 years of Other Non-Current Assets data on file, last reported at $11.4 million in Q1 2026.

  • On a quarterly basis, Other Non-Current Assets rose 5.88% year-over-year to $11.4 million in Q1 2026; TTM through Mar 2026 was $11.4 million, a 5.88% increase from a year earlier, with the FY2025 full-year figure at $11.6 million, up 12.97% from the prior year.
  • Other Non-Current Assets for Q1 2026 stood at $11.4 million, down from $11.6 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for SVRA reached as high as $11.6 million in Q4 2025 and fell as low as $116000.0 in Q4 2022.
  • Historically, Other Non-Current Assets has averaged $8.4 million across 5 years, with a median of $10.7 million in 2024.
  • Across the five-year window, Other Non-Current Assets plunged 98.97% in 2022 and soared 2561.5% in 2024, its largest moves.
  • Year by year, Other Non-Current Assets stood at $116000.0 in 2022, then soared by 233.62% to $387000.0 in 2023, then surged by 2561.5% to $10.3 million in 2024, then gained by 12.97% to $11.6 million in 2025, then retreated by 2.34% to $11.4 million in 2026.
  • Per Business Quant data, the three most recent Other Non-Current Assets figures were $11.4 million in Q1 2026, $11.6 million in Q4 2025, and $990000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 1.02 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 104.24 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.26 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.13 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 124.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 14.48 Mn
10 Savara 1.24 Bn 1.24 Bn - 11.36 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 11.36 Mn
Dec 31, 2025 11.64 Mn
Sep 30, 2025 990,000.00
Jun 30, 2025 11.63 Mn
Mar 31, 2025 10.73 Mn
Dec 31, 2024 10.30 Mn
Sep 30, 2024 11.11 Mn
Jun 30, 2024 10.63 Mn
Mar 31, 2024 10.71 Mn
Dec 31, 2023 387,000.00
Sep 30, 2023 10.50 Mn
Jun 30, 2023 10.78 Mn
Mar 31, 2023 10.82 Mn
Dec 31, 2022 116,000.00
Sep 30, 2022 9.75 Mn
Jun 30, 2022 952,000.00
Mar 31, 2022 11.06 Mn
Dec 31, 2021 11.27 Mn
Sep 30, 2021 1.05 Mn
Jun 30, 2021 11.83 Mn